Method Development And Validation Of Esomeprazole Delayed Release Capsules By Assay

By:

Contributor(s):

Publication details: Ooty JSSCPO 2023Description: 200DDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Barcode
M Pharm Thesis	JSS College of Pharmacy, Ooty	JSS College of Pharmacy, Ooty	Pharmaceutical Analysis	615.5 ADY (Browse shelf(Opens below))	Available	EPR2775

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	CONCURRENT ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ATORVASTATIN, GLIMEPIRIDE, METFORMIN AND RAMIPRIL BY RP-HPLC	STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF UDENAFIL AND CHARACTERIZATION OF DEGRADATION PRODUCTS BY RP-HPLC AND LC-MS/MS	A NOVEL LC-MS/MS METHOD FOR SIMULTANEOUS QUANTIFICATION OF RESVERATROL AND FERULIC ACID IN COMMERCIALLY AVAILABLE FACIAL OIL	615.5 ADY Method Development And Validation Of Esomeprazole Delayed Release Capsules By Assay	615.5 BAL An Stability Indicating Assay Method For Valsartan (Api) Isolation And Identification Of Nitrosamine Impurity By Rp-Hplc, Lc-Ms/Ms	615.5 BEL Related Impurity Determination In Active Pharmaceutical Ingredient Of Montelukast Sodium By Hplc	615.5 GOW Near Infrared Spectroscopic Method And Rp-Hplc Analysis Of Active Ingredient, Formulation And Degradation Products Of An Anti – Bacterial Drug Furazolidone By Lc-Ms/Ms	Next

There are no comments on this title.

to post a comment.